Biocept

Biocept We are dedicated to helping physicians improve outcomes for patients with metastatic cancer by delivering advanced diagnostic testing solutions. Biocept, Inc.

(Nasdaq: BIOC) develops and performs clinical laboratory tests to help patients with cancer that has metastasized to the central nervous system (CNS). Our CNSide™ assay provides enhanced detection and analysis of tumor cells and cell-free DNA from cerebrospinal fluid (CSF). Quantitative results help evaluate a patient’s response to treatment. Additional biomarkers can characterize genetic changes

associated with therapy resistance and identify new options for treating CNS metastasis. CNSide results from Biocept’s CLIA-certified and CAP-accredited laboratory help oncologists manage one of the most difficult complications of cancer, answering three critical questions: Is there tumor in the CSF? Is there a target for treatment? Is there a trend in treatment response? The Biocept team is dedicated to improving care for cancer patients – which means making a difference in people’s lives, every day. Biocept also provides RT-PCR based COVID-19 testing to support state and national public health efforts.

Address

San Diego, CA

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+18583208200

Website

Alerts

Be the first to know and let us send you an email when Biocept posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Biocept:

Shortcuts

Share

Category